Chemomab Therapeutics files updated corporate presentation on November 10, 2021

Chemomab Therapeutics Ltd.

Filed Form 8-K on Nov 10, 2021, including Items 7.01 (Regulation FD) and 9.01 (Exhibits).
Attached updated corporate presentation as Exhibit 99.1, highlighting treatments for fibrotic diseases.
Company based in Kiryat Atidim, Tel Aviv, with ADS trading on Nasdaq under ticker CMMB.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.